Of note, the administration of Reelin or PLGA‐PEG in combination with NSCs can significantly reduce the number of recruited astrocytes (GFAP+ cells) in the periphery and inside the necrotic sites compared to the control stroke group (Figure 8a,b). The gene discussed is RELN; the disease is stroke disorder.